Berliner Tageszeitung - Iran judiciary to rule on famed filmmaker's release: lawyer

NYSE - LSE

RIO	0.5%	105.88	$
NGG	-0.27%	81.62	$
BTI	-1.89%	61.165	$
CMSD	0.45%	22.36	$
GSK	-1.56%	52.225	$
RYCEF	2.63%	17.5	$
BCE	-0.96%	24.0455	$
BCC	0.97%	71.84	$
BP	-2.6%	41.695	$
JRI	0.81%	12.77	$
VOD	-3.29%	15.035	$
CMSC	0.04%	22.34	$
RBGPF	0%	60.72	$
AZN	-0.9%	177.152	$
RELX	-2.85%	32.805	$

Iran judiciary to rule on famed filmmaker's release: lawyer

BOULEVARD 21.01.2023

Iran's judiciary is to rule by Friday on whether to release celebrated filmmaker Jafar Panahi on bail after his conviction was overturned by the Supreme Court, his lawyer said Saturday.

Text size:

Panahi, 62, who has won a string of awards at European film festivals, was arrested on July 11 and had been due to serve a six-year sentence handed down in 2010 after his conviction for "propaganda against the system".

But on October 15, the Supreme Court quashed the conviction and ordered a retrial.

"Early this morning, judicial officials told me that they will make a decision about Panahi by the end of the week," his lawyer, Saleh Nikbakht, told AFP.

"Panahi's case had remained blocked in the courts since mid-October, but it was finally sent to the Court of Appeal on Monday to launch the legal proceedings.

"By law, he should immediately be released on bail and his case reviewed again," the lawyer said.

Panahi won a Golden Lion at the Venice Film Festival in 2000 for his film "The Circle". In 2015, he won the Golden Bear at Berlin for "Taxi Tehran", while in 2018, he won the best screenplay prize at Cannes for "Three Faces".

Panahi's conviction followed his support for mass protests in 2009 against the disputed results of that year's presidential election which saw populist Mahmoud Ahmadinejad win a second term.

As well as the six-year jail term, the court sentenced Panahi to a 20-year ban on directing or writing films, travelling or even speaking to the media. However, he has continued to live and work in Iran.

According to his lawyer, Panahi already suffered from health problems before his arrest and contracted a serious skin disease in prison.

Doctors say he needs to be treated "outside prison", the lawyer added.

Panahi's July arrest came after he attended a court hearing for fellow film director Mohammad Rasoulof, who had been detained a few days earlier.

Rasoulof was released from prison on January 7 after being granted a two-week furlough for health reasons, his lawyer told AFP.

Separately, a court ordered the release on bail of activist Arash Sadeghi, who was detained during mass protests in October against the death in custody of Masha Amini following her arrest for an alleged breach of Iran's strict dress code for women, the Etemad newspaper reported.

P. Hansen--BTZ

Featured

'They want to destroy us': Shock and anger as Russian attack sets Kyiv cathedral ablaze

Father Makariy, a high-ranking clergyman at Kyiv's Pechersk Lavra monastery complex, was woken at around 5:00 am with a huge roar -- the cathedral at the heart of one of Orthodox Christianity's most important sites had been set on fire in a Russian attack.

Burnt-out Indonesians beat the blues with children's games

Flushed and sweating, 31-year-old Annisa Enggracia Fidel runs back and forth to defend her fort from invaders -- hundreds of fellow adults all beating the blues by playing a nostalgic Indonesian children's game.

Greek fishermen struggle to keep up with pufferfish invaders

On his fishing boat moored in the Greek port of Ierapetra in southwestern Crete, Alexis Charlambakis pries open the mouth of a freshly-caught pufferfish to reveal two massive teeth on each jaw.

BioNxt Engages Business Development & Licensing Advisors for Commercialization of Patented Sublingual Cladribine ODF

VANCOUVER, BC / ACCESS Newswire / June 15, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that it has commenced work with a Business Development & Licensing ("BD&L") specialist advisor to support the commercialization and partnering strategy for BNT23001, the Company's patented proprietary sublingual Cladribine orally dissolvable film ("ODF") formulation for the treatment of multiple sclerosis ("MS").